What are the survival rates for locally advanced Liver Cancer
Survival Rates for Locally Advanced Liver Cancer
I appreciate your question about survival outcomes. Let me explain what we know from current medical evidence, while being clear about the important context around these numbers.
Understanding "Locally Advanced" Liver Cancer
First, it's helpful to clarify what "locally advanced" means in liver cancer. This typically refers to hepatocellular carcinoma (HCC) that:
- Has grown beyond early-stage size but hasn't spread to distant organs
- May involve blood vessels in or near the liver
- Requires more aggressive treatment than early-stage disease
What the Evidence Shows
According to NCCN Guidelines for Hepatocellular Carcinoma, survival outcomes depend heavily on which treatment approach is used:
After Surgical Resection (Removal)
- Studies show 5-year survival rates of 50% or higher for patients with early-stage HCC treated with radiofrequency ablation (RFA), a minimally invasive technique
- For surgical resection in selected patients, outcomes vary based on tumor characteristics and liver function
After Liver Transplantation
For patients who undergo downstaging (shrinking the tumor with initial treatment) followed by liver transplant:
- 5-year tumor-free survival: 77% (compared to 18% without transplant)
- 5-year overall survival: 78% (compared to 31% without transplant)
- 10-year survival rates: 52.1% with downstaging therapy
With Locoregional Therapies
The NCCN Guidelines note that response to treatment (measured by tumor shrinkage on imaging) is a strong predictor of survival, but specific survival percentages vary based on individual factors.
Why These Numbers Vary So Much
Survival rates for locally advanced liver cancer depend on several critical factors:
- Liver function - How well your remaining liver works (measured by Child-Turcotte-Pugh score)
- Tumor characteristics - Size, number of tumors, whether blood vessels are involved
- Treatment approach - Surgery, transplant, ablation, or combination approaches
- Underlying liver disease - Whether you have cirrhosis, hepatitis B or C
- Overall health - Your ability to tolerate treatment
Important Context
⚠️ These are population averages, not predictions for individual patients. Your specific situation—your liver function, tumor stage, overall health, and which treatments you're eligible for—will significantly influence your personal outlook.
Questions to Ask Your Oncology Team
To understand YOUR specific situation better, consider asking:
- "Based on my tumor stage and liver function, what survival outcomes have been reported for patients like me?"
- "Which treatment options am I a candidate for, and what are the survival differences between them?"
- "What does 'response to treatment' mean, and how will we measure whether my treatment is working?"
- "Are there clinical trials available that might offer additional options?"
- "How will we monitor for recurrence, and what's the plan if the cancer returns?"
Where to Learn More
The NCCN Guidelines for Hepatocellular Carcinoma (Version 2.2025) provide detailed information about treatment selection and outcomes based on tumor stage and liver function. Your care team can access these to discuss your specific prognosis.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Liver Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated May 15, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Liver Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with prognosis for Liver Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Liver Cancer
- What biomarker testing is recommended for locally advanced Liver Cancer
- What clinical trials are available for locally advanced Liver Cancer
- What is the standard of care for locally advanced Liver Cancer according to NCCN guidelines
- How long do I have to live with Liver Cancer
- What does progression mean for Liver Cancer and what happens next
- What should caregivers know about Liver Cancer treatment
- What is oligometastatic Liver Cancer and can it be cured
- How is Liver Cancer that has spread to the liver treated